News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Schneiderman Daniel H
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2022 |
4
| Schneiderman Daniel H (CFO) has filed a Form 4 on Pasithea Therapeutics Corp.|
Txns:
| Granted 300,000 options to buy
@ $1.26, valued at
$378k
|
|
| 08/15/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/03/2022 |
4
| Schneiderman Daniel H (CFO) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Granted 10,000 options to buy
@ $1.45, valued at
$14.5k
|
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2020 |
4
| Schneiderman Daniel H (CFO) has filed a Form 4 on AzurRx BioPharma, Inc.|
Txns:
| Disposed of 35,006 options to buy
@ $1.03, valued at
$36.1k
Granted 35,006 options to buy
@ $0.85, valued at
$29.8k
Granted 250,000 options to buy
@ $0.85, valued at
$212.5k
|
|
| 01/09/2020 |
4
| Schneiderman Daniel H (CFO) has filed a Form 4 on AzurRx BioPharma, Inc.|
Txns:
| Granted 335,006 options
@ $1.03, valued at
$345.1k
|
|
| 01/09/2020 |
3
| Schneiderman Daniel H (CFO) has filed a Form 3 on AzurRx BioPharma, Inc. |
| 01/17/2018 |
4
| Schneiderman Daniel H (VP OF FINANCE AND SECRETARY) has filed a Form 4 on MetaStat, Inc.|
Txns:
| Acquired 76,962 options to buy
@ $0.93, valued at
$71.6k
|
|
| 04/06/2017 |
4
| Schneiderman Daniel H (VP OF FINANCE AND SECRETARY) has filed a Form 4 on MetaStat, Inc.|
Txns:
| Disposed of 25,000 options to buy
@ $3, valued at
$75k
|
|
| 07/08/2016 |
4
| Schneiderman Daniel H (VP OF FINANCE AND SECRETARY) has filed a Form 4 on MetaStat, Inc.|
Txns:
| Granted 120,000 options to buy
@ $2, valued at
$240k
|
|
| 03/18/2016 |
4
| Schneiderman Daniel H (VP OF FINANCE AND SECRETARY) has filed a Form 4 on MetaStat, Inc.|
Txns:
| Granted 20,000 options to buy
@ $3.55, valued at
$71k
|
|
|
|